{"transactions":[{"id":841378,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2026-03-16T23:16:37.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":3.16,"value":316000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 21, 2027, and 1/48th of the total number of shares subject to the option vest at the end of each calendar month thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":175000,"derivative":{"exercise_price":3.16,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001843113-26-000006","document":"wk-form4_1773702995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311326000006/wk-form4_1773702995.xml","form_type":"4"}},{"id":841377,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-16T23:16:37.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 21, 2026, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":839834,"source":{"system":"sec-edgar","filing":"0001843113-26-000006","document":"wk-form4_1773702995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311326000006/wk-form4_1773702995.xml","form_type":"4"}},{"id":861101,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T20:00:02.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":2535,"price":3.077,"value":7800.195,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock purchased through ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":689834,"source":{"system":"sec-edgar","filing":"0001843113-26-000004","document":"wk-form4_1772654400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311326000004/wk-form4_1772654400.xml","form_type":"4"}},{"id":861100,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-04T20:00:02.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":15698,"price":3.62,"value":56826.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":687299,"source":{"system":"sec-edgar","filing":"0001843113-26-000004","document":"wk-form4_1772654400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311326000004/wk-form4_1772654400.xml","form_type":"4"}},{"id":881740,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T00:11:33.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":11430,"price":3.61,"value":41262.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":702997,"source":{"system":"sec-edgar","filing":"0001843113-26-000002","document":"wk-form4_1772064690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311326000002/wk-form4_1772064690.xml","form_type":"4"}},{"id":1015800,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-20T21:20:07.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":31787,"price":11.8161,"value":375598.3707,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":714427,"source":{"system":"sec-edgar","filing":"0001843113-25-000003","document":"wk-form4_1760995204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311325000003/wk-form4_1760995204.xml","form_type":"4"}},{"id":1227438,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-04T23:48:32.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":8621,"price":2.465,"value":21250.765,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan (\"ESPP\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock purchased through ESPP in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":746214,"source":{"system":"sec-edgar","filing":"0001274737-25-000013","document":"wk-form4_1741132105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000013/wk-form4_1741132105.xml","form_type":"4"}},{"id":1245659,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option(right to buy)","published_at":"2025-02-26T01:59:07.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":3.58,"value":268500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 21, 2026, and 1/48th of the total number of shares subject to the option vest at the end of each calendar month thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":75000,"derivative":{"exercise_price":3.58,"expiration_date":"2035-02-20","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001274737-25-000010","document":"wk-form4_1740535140.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000010/wk-form4_1740535140.xml","form_type":"4"}},{"id":1245658,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-26T01:59:07.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's  common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 21, 2025, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":737593,"source":{"system":"sec-edgar","filing":"0001274737-25-000010","document":"wk-form4_1740535140.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473725000010/wk-form4_1740535140.xml","form_type":"4"}},{"id":1361582,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-18T23:32:33.000Z","date":"2024-11-14","kind":"purchase","planned":false,"acquired":true,"shares":24305,"price":2.81,"value":68297.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.72 to $2.94, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4."}],"balance_after":689799,"source":{"system":"sec-edgar","filing":"0001274737-24-000094","document":"wk-form4_1731972745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000094/wk-form4_1731972745.xml","form_type":"4"}},{"id":1514048,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-05-17T00:02:50.000Z","date":"2024-05-16","kind":"purchase","planned":false,"acquired":true,"shares":40401,"price":1.92,"value":77569.92,"ownership":{"direct":false,"nature":"by Spouse"},"balance_after":40401,"source":{"system":"sec-edgar","filing":"0001274737-24-000052","document":"wk-form4_1715904159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000052/wk-form4_1715904159.xml","form_type":"4"}},{"id":1602687,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-04T21:08:29.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":9804,"price":1.91,"value":18725.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased through Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":600788,"source":{"system":"sec-edgar","filing":"0001274737-24-000015","document":"wk-form4_1709586311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000015/wk-form4_1709586311.xml","form_type":"4"}},{"id":1625052,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-22T21:09:40.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 175,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time."}],"balance_after":590984,"source":{"system":"sec-edgar","filing":"0001274737-24-000012","document":"wk-form4_1708636160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000012/wk-form4_1708636160.xml","form_type":"4"}},{"id":1757999,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-10-18T20:05:21.000Z","date":"2023-10-17","kind":"sale","planned":false,"acquired":false,"shares":33819,"price":1.7451,"value":59017.5369,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on October 16, 2022."}],"balance_after":415984,"source":{"system":"sec-edgar","filing":"0001274737-23-000094","document":"wk-form4_1697659512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000094/wk-form4_1697659512.xml","form_type":"4"}},{"id":1786882,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-06T21:05:34.000Z","date":"2023-08-31","kind":"grant","planned":false,"acquired":true,"shares":9803,"price":2.142,"value":20998.026,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased through Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":449803,"source":{"system":"sec-edgar","filing":"0001274737-23-000091","document":"wk-form4_1694034315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000091/wk-form4_1694034315.xml","form_type":"4"}},{"id":2091003,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-09T14:00:22.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":90000,"price":2.68,"value":241200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.75, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4."}],"balance_after":440000,"source":{"system":"sec-edgar","filing":"0001274737-22-000083","document":"wf-form4_167059440451764.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473722000083/wf-form4_167059440451764.xml","form_type":"4"}},{"id":2135401,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":60594,"kind":"person","name":"ABALLI JOHN","position":1,"cik":"0001843113","reported_name":"ABALLI JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2022-10-19T00:38:11.000Z","date":"2022-10-16","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of October 16, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":350000,"source":{"system":"sec-edgar","filing":"0001843113-22-000010","document":"wf-form4_166613985172902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000184311322000010/wf-form4_166613985172902.xml","form_type":"4"}}]}